#EarningsSeason #BinancePick
Growth analysis for $LLY
Adding another prediction to #EarningsSeason with the help of #BinancePick! Today, I’m sharing my arguments under Approach 1 for why Eli Lilly ($LLY) will beat this quarter’s financial expectations.
Why bet “Yes” on Eli Lilly?
The undisputed catalyst for $LLY remains the massive, unprecedented global demand for its leading weight-loss and diabetes treatments (Mounjaro and Zepbound). The company is aggressively expanding its production capacity to supply international markets, which will translate into a direct and substantial increase in its reported revenue.
In addition, its strong pipeline and recent regulatory approvals in new markets strengthen its competitive position against the broader pharmaceutical sector, ensuring exceptionally high operating margins.
I’ve attached a screenshot of my prediction submitted on Binance Pick. Best of luck to all the creators and traders on the leaderboard!
Related symbols: LLY MSFT AMZN GOOGL V
Growth analysis for $LLY
Adding another prediction to #EarningsSeason with the help of #BinancePick! Today, I’m sharing my arguments under Approach 1 for why Eli Lilly ($LLY) will beat this quarter’s financial expectations.
Why bet “Yes” on Eli Lilly?
The undisputed catalyst for $LLY remains the massive, unprecedented global demand for its leading weight-loss and diabetes treatments (Mounjaro and Zepbound). The company is aggressively expanding its production capacity to supply international markets, which will translate into a direct and substantial increase in its reported revenue.
In addition, its strong pipeline and recent regulatory approvals in new markets strengthen its competitive position against the broader pharmaceutical sector, ensuring exceptionally high operating margins.
I’ve attached a screenshot of my prediction submitted on Binance Pick. Best of luck to all the creators and traders on the leaderboard!
Related symbols: LLY MSFT AMZN GOOGL V
